Centerpoint Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $990K | Hold |
2,015
| – | – | 0.32% | 37 |
|
|
2025
Q4 | $1.17M | Hold |
2,015
| – | – | 0.36% | 34 |
|
|
2025
Q3 | $977K | Buy |
2,015
+38
| +2% | +$17.7K | 0.3% | 39 |
|
|
2025
Q2 | $802K | Sell |
1,977
-123
| -6% | -$51.4K | 0.27% | 39 |
|
|
2025
Q1 | $1.04M | Sell |
2,100
-215
| -9% | -$116K | 0.39% | 31 |
|
|
2024
Q4 | $1.2M | Sell |
2,315
-15
| -0.6% | -$8.25K | 0.42% | 31 |
|
|
2024
Q3 | $1.44M | Sell |
2,330
-15
| -0.6% | -$8.88K | 0.5% | 24 |
|
|
2024
Q2 | $1.3M | Hold |
2,345
| – | – | 0.47% | 27 |
|
|
2024
Q1 | $1.36M | Sell |
2,345
-140
| -6% | -$78.6K | 0.51% | 26 |
|
|
2023
Q4 | $1.32M | Sell |
2,485
-184
| -7% | -$89.1K | 0.52% | 28 |
|
|
2023
Q3 | $1.35M | Buy |
2,669
+175
| +7% | +$93.3K | 0.57% | 26 |
|
|
2023
Q2 | $1.3M | Sell |
2,494
-629
| -20% | -$339K | 0.53% | 27 |
|
|
2023
Q1 | $1.8M | Sell |
3,123
-97
| -3% | -$54.7K | 0.78% | 24 |
|
|
2022
Q4 | $1.77M | Sell |
3,220
-167
| -5% | -$88.5K | 0.83% | 24 |
|
|
2022
Q3 | $1.72M | Sell |
3,387
-750
| -18% | -$420K | 0.91% | 19 |
|
|
2022
Q2 | $2.25M | Sell |
4,137
-530
| -11% | -$292K | 1.15% | 19 |
|
|
2022
Q1 | $2.76M | Sell |
4,667
-979
| -17% | -$562K | 1.26% | 18 |
|
|
2021
Q4 | $3.77M | Sell |
5,646
-1,020
| -15% | -$637K | 1.65% | 16 |
|
|
2021
Q3 | $3.81M | Sell |
6,666
-3,604
| -35% | -$1.98M | 1.82% | 16 |
|
|
2021
Q2 | $5.18M | Buy |
10,270
+8,354
| +436% | +$3.94M | 2.44% | 14 |
|
|
2021
Q1 | $874K | Hold |
1,916
| – | – | 0.51% | 24 |
|
|
2020
Q4 | $892K | Hold |
1,916
| – | – | 0.58% | 24 |
|
|
2020
Q3 | $846K | Buy |
1,916
+2
| +0.1% | +$826 | 0.64% | 23 |
|
|
2020
Q2 | $694K | Sell |
1,914
-506
| -21% | -$170K | 0.56% | 27 |
|
|
2020
Q1 | $686K | Buy |
2,420
+624
| +35% | +$197K | 0.68% | 22 |
|
|
2019
Q4 | $583K | Hold |
1,796
| – | – | 0.43% | 25 |
|
|
2019
Q3 | $523K | Hold |
1,796
| – | – | 0.42% | 24 |
|
|
2019
Q2 | $527K | Hold |
1,796
| – | – | 0.42% | 24 |
|
|
2019
Q1 | $492K | Hold |
1,796
| – | – | 0.42% | 24 |
|
|
2018
Q4 | $402K | Hold |
1,796
| – | – | 0.38% | 26 |
|
|
2018
Q3 | $438K | Hold |
1,796
| – | – | 0.35% | 22 |
|
|
2018
Q2 | $372K | Sell |
1,796
-180
| -9% | -$38.2K | 0.31% | 24 |
|
|
2018
Q1 | $408K | Hold |
1,976
| – | – | 0.36% | 20 |
|
|
2017
Q4 | $375K | Buy |
+1,976
| New | +$379K | 0.33% | 19 |
|
Other funds holding TMO
VCM
Centerpoint Advisors's TMO Position: Q1 2026 in Review
Centerpoint Advisors held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 2,015 shares worth $990K. The position accounts for 0.32% of the portfolio, ranked #37.
Centerpoint Advisors first reported a position in TMO in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.18M in Q2 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Centerpoint Advisors held 2,015 shares of Thermo Fisher Scientific worth $990K as of Q1 2026.
- Centerpoint Advisors left its Thermo Fisher Scientific share count unchanged in Q1 2026.
- Thermo Fisher Scientific made up 0.32% of Centerpoint Advisors's portfolio in Q1 2026, its #37 holding.
- Centerpoint Advisors first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 34 quarters since.
- Centerpoint Advisors's Thermo Fisher Scientific position peaked at $5.18M in Q2 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Centerpoint Advisors's 13F filing for Q1 2026, filed 7 May 2026.